1
|
Speel EJ, Radonic T, Dafni U, Thunnissen E, Rüschoff J, Kowalski J, Kerr K, Bubendorf L, Valero IS, Joseph L, Navarro A, Monkhorst K, Madsen L, Losa JH, Biernat W, Dellaporta T, Kammler R, Peters S, Stahel R, Finn S. 191P ROS1 fusions in resected stage I-III adenocarcinoma (ADC): A Lungscape ETOP study. J Thorac Oncol 2023. [DOI: 10.1016/s1556-0864(23)00444-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2023]
|
2
|
Taniere P, Nicholson A, Gosney J, Joseph L, Shaw E, Lanctot A, Bains R, Ryan J. PATHways UK survey: Pathology perceptions on current biomarker testing and pathways for breast cancer in England. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01595-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
3
|
Lascarrou JB, Dumas F, Bougouin W, Legriel S, Aissaoui N, Deye N, Beganton F, Lamhaut L, Jost D, Vieillard-Baron A, Nichol G, Marijon E, Jouven X, Cariou A, Agostinucci J, Aissaoui-Balanant N, Algalarrondo V, Alla F, Alonso C, Amara W, Annane D, Antoine C, Aubry P, Azoulay E, Beganton F, Billon C, Bougouin W, Boutet J, Bruel C, Bruneval P, Cariou A, Carli P, Casalino E, Cerf C, Chaib A, Cholley B, Cohen Y, Combes A, Coulaud J, Da Silva D, Das V, Demoule A, Denjoy I, Deye N, Diehl J, Dinanian S, Domanski L, Dreyfuss D, Dubois-Rande J, Dumas F, Duranteau J, Empana J, Extramiana F, Fagon J, Fartoukh M, Fieux F, Gandjbakhch E, Geri G, Guidet B, Halimi F, Henry P, Jabre P, Joseph L, Jost D, Jouven X, Karam N, Lacotte J, Lahlou-Laforet K, Lamhaut L, Lanceleur A, Langeron O, Lavergne T, Lecarpentier E, Leenhardt A, Lellouche N, Lemiale V, Lemoine F, Linval F, Loeb T, Ludes B, Luyt C, Mansencal N, Mansouri N, Marijon E, Maury E, Maxime V, Megarbane B, Mekontso-Dessap A, Mentec H, Mira J, Monnet X, Narayanan K, Ngoyi N, Perier M, Piot O, Plaisance P, Plaud B, Plu I, Raphalen J, Raux M, Revaux F, Ricard J, Richard C, Riou B, Roussin F, Santoli F, Schortgen F, Sharshar T, Sideris G, Spaulding C, Teboul J, Timsit J, Tourtier J, Tuppin P, Ursat C, Varenne O, Vieillard-Baron A, Voicu S, Wahbi K, Waldmann V. Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness: Insights From Two International Data Sets. Chest 2022; 163:1120-1129. [PMID: 36445800 DOI: 10.1016/j.chest.2022.10.023] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2022] [Revised: 10/10/2022] [Accepted: 10/23/2022] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND Recent guidelines have emphasized actively avoiding fever to improve outcomes in patients who are comatose following resuscitation from cardiac arrest (ie, out-of-hospital cardiac arrest). However, whether targeted temperature management between 32 °C and 36 °C (TTM32-36) can improve neurologic outcome in some patients remains debated. RESEARCH QUESTION Is there an association between the use of TTM32-36 and outcome according to severity assessed at ICU admission using a previously derived risk score? STUDY DESIGN AND METHODS Data prospectively collected in the Sudden Death Expertise Center (SDEC) registry (France) between May 2011 and December 2017 and in the Resuscitation Outcomes Consortium Continuous Chest Compressions (ROC-CCC) trial (United States and Canada) between June 2011 and May 2015 were used for this study. Severity at ICU admission was assessed through a modified version of the Cardiac Arrest Hospital Prognosis (mCAHP) score, divided into tertiles of severity. The study explored associations between TTM32-36 and favorable neurologic status at hospital discharge by using multiple logistic regression as well as in tertiles of severity for each data set. RESULTS A total of 2,723 patients were analyzed in the SDEC data set and 4,202 patients in the ROC-CCC data set. A favorable neurologic status at hospital discharge occurred in 728 (27%) patients in the French data set and in 1,239 (29%) patients in the North American data set. Among the French data set, TTM32-36 was independently associated with better neurologic outcome in the tertile of patients with low (adjusted OR, 1.63; 95% CI, 1.15-2.30; P = .006) and high (adjusted OR, 1.94; 95% CI, 1.06-3.54; P = .030) severity according to mCAHP at ICU admission. Similar results were observed in the North American data set (adjusted ORs of 1.36 [95% CI, 1.05-1.75; P = .020] and 2.42 [95% CI, 1.38-4.24; P = .002], respectively). No association was observed between TTM32-36 and outcome in the moderate groups of the two data sets. INTERPRETATION TTM32-36 was significantly associated with a better outcome in patients with low and high severity at ICU admission assessed according to the mCAHP score. Further studies are needed to evaluate individualized temperature control following out-of-hospital cardiac arrest.
Collapse
Affiliation(s)
- Jean Baptiste Lascarrou
- Université Paris Cité, INSERM, PARCC, Paris, France; Médecine Intensive Réanimation, University Hospital Center, Nantes, France; AfterROSC Network Group, Paris, France.
| | - Florence Dumas
- Université Paris Cité, INSERM, PARCC, Paris, France; Emergency Department, Cochin University Hospital, APHP, Paris, France
| | - Wulfran Bougouin
- Université Paris Cité, INSERM, PARCC, Paris, France; AfterROSC Network Group, Paris, France; Medical-Surgical Intensive Care Unit, Hopital Privé Jacques Cartier, Massy, France
| | - Stephane Legriel
- Université Paris Cité, INSERM, PARCC, Paris, France; AfterROSC Network Group, Paris, France; Medical Surgical Intensive Care Unit, Mignot Hospital, Le Chesnay, France
| | - Nadia Aissaoui
- Université Paris Cité, INSERM, PARCC, Paris, France; AfterROSC Network Group, Paris, France; Medical Intensive Care Unit, Cochin Hospital (APHP) and University of Paris, Paris, France
| | - Nicolas Deye
- AfterROSC Network Group, Paris, France; Medical Intensive Care Unit, Lariboisière University Hospital, INSERM U942, Paris, France
| | | | - Lionel Lamhaut
- AfterROSC Network Group, Paris, France; SAMU de Paris-DAR Necker University Hospital-Assistance, Paris, France
| | - Daniel Jost
- Brigade des Sapeurs-Pompiers de Paris, Paris, France
| | - Antoine Vieillard-Baron
- Medical Intensive Care Unit, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt, France
| | - Graham Nichol
- University of Washington-Harborview Center for Prehospital Emergency Care, University of Washington, Seattle, WA
| | - Eloi Marijon
- Université Paris Cité, INSERM, PARCC, Paris, France
| | | | - Alain Cariou
- Université Paris Cité, INSERM, PARCC, Paris, France; AfterROSC Network Group, Paris, France; Medical Intensive Care Unit, Cochin Hospital (APHP) and University of Paris, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Cassidy M, Hayes R, Nevin R, Griffin A, Herbst J, Mealy B, Walsh K, Donnelly R, Harrison H, Jariol A, Joseph L, Carroll KM. 301 BENEFITS OF ENVIRONMENTAL MUSIC THERAPY IN AN ACUTE HOSPITAL. Age Ageing 2022. [DOI: 10.1093/ageing/afac218.264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Environmental Music Therapy (EMT) uses live music played by a music therapist to enhance the surrounding environment and is increasingly used in clinical settings. Studies show that EMT may reduce anxiety, enhance wellbeing, promote better communication between patients and staff, and reduce patient perception of waiting times in hospital. We aimed to explore the benefit of EMT for older adults in a geriatric outpatient setting and on rehabilitation wards.
Methods
Harp music was played by a music therapist in the vicinity of ambulatory clinics and on rehabilitation wards for 4 hours per week (over a 2-day period) for 20 weeks. Music exposure on any given day was to an estimated 50 outpatients, as well as 50 people passing the vicinity or to about 30 patients on the rehabilitation ward. Music was selected and played in a dynamic process, responding to verbal and non-verbal reactions of patients, family, and staff. Voluntary responses were recorded and collated.
Results
There were 36 recorded responses and all reflected positively on EMT. Patients cited that the music created a welcoming space and stimulated interaction and conversation. Several patients waiting for their clinic appointment noted that it distracted from fearful expectation and was a source of comfort. Some commented that they felt more relaxed and that it reduced stress. On rehabilitation wards, patients found familiar music to be calming with nurses citing that it stimulated social interaction between patients, family and staff. Responses to EMT gave insights that resulted in patient referrals for music therapy.
Conclusion
Environmental music played by a music therapist was found to modify patient hospital experiences. In particular, it appeared to reduce self-perceived stress and stimulate positive social interaction and conversation. This supports the use of EMT to advance the integration of the arts for wellbeing in an acute hospital.
Collapse
Affiliation(s)
- M Cassidy
- St. James's Hospital Creative Life Centre, Mercer's Institute for Successful Ageing, , Dublin, Ireland
| | - R Hayes
- St. James's Hospital Creative Life Centre, Mercer's Institute for Successful Ageing, , Dublin, Ireland
| | - R Nevin
- St. James's Hospital Creative Life Centre, Mercer's Institute for Successful Ageing, , Dublin, Ireland
| | - A Griffin
- St. James's Hospital Occupational Therapy Department, , Dublin, Ireland
| | - J Herbst
- St. James's Hospital Medical Social Work Department, , Dublin, Ireland
| | - B Mealy
- St. James's Hospital Physiotherapy Department, , Dublin, Ireland
| | - K Walsh
- St. James's Hospital Speech and Language Therapy Department, , Dublin, Ireland
| | - R Donnelly
- St. James’s Hospital Medicine for the Elderly Department, , Dublin, Ireland
| | | | | | - L Joseph
- St. James’s Hospital Medicine for the Elderly Department, , Dublin, Ireland
| | - KM Carroll
- St. James's Hospital Creative Life Centre, Mercer's Institute for Successful Ageing, , Dublin, Ireland
| |
Collapse
|
5
|
Zubiena L, Lewin O, Ogunfiditimi G, Coleman R, Phezulu J, Blackburn T, Joseph L. Development and testing of the Health Information Website Evaluation Tool (HIWET) – An inter-rater reliability analysis study. Physiotherapy 2022. [DOI: 10.1016/j.physio.2021.12.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
6
|
Corbasson A, Meunier B, Lecoeur E, Jannot A, Khimoud D, Namaoui W, Joseph L, Arlet J. Tolérance du vaccin anti-COVID19 chez les patients drépanocytaires adultes. Rev Med Interne 2021. [PMCID: PMC8610706 DOI: 10.1016/j.revmed.2021.10.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Introduction Les patients drépanocytaires adultes sont considérés depuis le début de l’épidémie comme plus fragiles face à la COVID-19. L’analyse de la littérature et des travaux Français montrent que les patients de génotype SC et les plus de 40 ans sont les plus à risque de développer des formes sévères. De plus, des crises vaso-occlusives (CVO) peuvent être provoquées par l’infection, ce qui conduit à des hospitalisations plus fréquentes dans cette population. La vaccination prioritaire a donc été recommandée. Cependant, la tolérance du vaccin n’a pas été étudiée dans cette population, notamment le risque de crise induite par l’inflammation ou la fièvre post-vaccinale. Nous avons souhaité étudier les complications liées au vaccins anti-COVID19 dans une cohorte consécutive de patients drépanocytaires adultes. Patients et méthodes Étude observationnelle rétrospective réalisée sur une cohorte de patients d’un centre de référence Français. Tous les patients de notre cohorte, vaccinés jusqu’au 31 juillet 2021, ont été rappelés systématiquement dans les 2 mois suivant leur injection pour connaître les effets secondaires des vaccins. En plus des effets secondaires attendus, était notifié s’ils avaient eu des CVO à domicile ou des hospitalisations dans les 21 jours suivant le vaccin. La prévalence de CVO hospitalisées a été comparée à celle survenue dans les 3 semaines chez tous les patients drépanocytaires non vaccinés, venus dans la même période en consultation ou hospitalisation de jour (HDJ) dans notre centre. Résultats Sur une cohorte active d’environ 300 patients, seuls 100 patients drépanocytaires (68 % homozygotes, 22 % de génotype SC ; 55 % de femmes) étaient vaccinés au 31/07/2021. 95 % ont reçu un schéma vaccinal complet. 93 patients ont reçu le vaccin Pfizer, 3 le Moderna, 4 l’Astra Zeneca. L’âge médian des sujets vaccinés était de 30 ans (extrêmes 18-67). L’incidence des hospitalisations dans les 3 semaines était de 12 % après la première dose : 9 CVO simples, une CVO avec syndrome thoracique aigu, une thrombose veineuse profonde dans le bras injecté, une CVO avec séquestration splénique et rupture de rate entraînant un décès. Parmi ces 12 patients, quatre avaient été vaccinés dans les 30 jours suivant une CVO hospitalisée (incluant le patient décédé, vacciné à la fin d’une hospitalisation pour CVO). Dans la même période, l’incidence des hospitalisations sur notre cohorte de patients vus en consultation ou HDJ était de 9 % à 3 semaines (27/285) (P = 0,58, comparaison non significative par rapport aux vaccinés). Des CVO gérées à domicile ont été rapportées par 4 patients ayant reçu leur première dose. Les autres complications les plus fréquentes survenant dans les 48 heures suivant la première injection vaccinale étaient les suivantes : douleur musculaire au point d’injection (31 %), asthénie (23 %), courbatures (13 %), céphalées (13 %), fièvre (12 %), [MOU1] [A2] frissons (3 %), nausées (2 %), douleurs oculaires (1 %), orgelet (1 %), règles très douloureuses (1 %), diarrhées (1 %), malaise (1 %), vertiges rotatoires (1 %). Parmi les patients avec fièvre, seuls 2/12 ont été hospitalisés pour CVO. Enfin, seuls deux des 78 patients ayant eu la deuxième injection (2,5 %) ont été hospitalisés dans les 3 semaines (2 CVO). [MOU1]Peut être pas pour l’abstract mais il faudrait regarder si la majortité de ces 12 patients avec fièvre ne sont pas ceux qui ont été hospitalisés. si c’est la cas on pourra rajouter une phrase en ce sens [A2]3 de ces patients ont fait une CVO et seulement 2 ont été hospitalisés. Conclusion La tolérance du vaccin anti-COVID19 est très acceptable chez le patient drépanocytaire adulte, avec des effets secondaires minimes, proches de ceux de la population générale. Nos résultats rassurent sur le risque potentiel de CVO nécessitant une hospitalisation induite par l’injection vaccinale, même si la prudence imposerait de se placer à distance d’une crise pour la réalisation du vaccin. Ces résultats devraient diminuer l’appréhension d’une population à risque de la COVID-19 mais réticente à la vaccination, comme le montre le taux insuffisant de patients vaccinés dans notre cohorte, pourtant régulièrement incités à se faire vacciner depuis mars 2021.
Collapse
|
7
|
Navarro I, Joseph L, Liu Z, Berlin A, Helou J, Raman S, Weersink R, Rink A, Lao B, Menard C, Chung P. Physician and Patient Reported Morbidity After MR-Guided Salvage Brachytherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
8
|
Omar S, Ismail F, Joseph L, Ngcamu D, Okozi N, van der Meulen M, Gwala T, Bhyat Z, Sicwetsha A, de Abreu C, Danisa L, Makubalo L, Ismail N. Bedaquiline resistance and genetic resistance associated variants: South African National Bedaquiline Surveillance program 2014–2019. Int J Infect Dis 2020. [DOI: 10.1016/j.ijid.2020.09.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
9
|
Nichols M, Stevenson L, Koski L, Basler C, Wise M, Whitlock L, Francois Watkins L, Friedman CR, Chen J, Tagg K, Joseph L, Caidi H, Patel K, Tolar B, Hise K, Classon A, Ceric O, Reimschuessel R, Williams IT. Detecting national human enteric disease outbreaks linked to animal contact in the United States of America. REV SCI TECH OIE 2020; 39:471-480. [PMID: 33046928 DOI: 10.20506/rst.39.2.3098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Enteric pathogens, such as non-typhoidal Salmonella, Campylobacter and Escherichia coli, can reside in the intestinal tract of many animals, including livestock, companion animals, small mammals and reptiles. Often, these animals can appear healthy; nonetheless, humans can become infected after direct or indirect contact, resulting in a substantial illness burden. An estimated 14% of the 3.2 million illnesses that occur in the United States of America (USA) each year from such enteric pathogens are attributable to animal contact. Surveillance for enteric pathogens in the USA includes the compilation and interpretation of both laboratory and epidemiologic data. However, the authors feel that a collaborative, multisectoral and transdisciplinary - or One Health - approach is needed for data collection and analysis, at every level. In addition, they suggest that the future of enteric illness surveillance lies in the development of improved technologies for pathogen detection and characterisation, such as genomic sequencing and metagenomics. In particular, using whole-genome sequencing to compare genetic sequences of enteric pathogens from humans, food, animals and the environment, can help to predict antimicrobial resistance among these pathogens, determine their genetic relatedness and identify outbreaks linked to a common source. In this paper, the authors describe three recent, multi-state human enteric illness outbreaks linked to animal contact in the USA and discuss how integrated disease surveillance was essential to outbreak detection and response. Additional datasharing between public health and animal health laboratories and epidemiologists at the local, national, regional and international level may help to improve surveillance for emerging animal and human health threats and lead to new opportunities for prevention.
Collapse
|
10
|
Shamriz O, Simon AJ, Lev A, Megged O, Ledder O, Picard E, Joseph L, Molho-Pessach V, Tal Y, Millman P, Slae M, Somech R, Toker O, Berger M. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation. Clin Exp Immunol 2020; 200:215-227. [PMID: 32201938 DOI: 10.1111/cei.13432] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2020] [Revised: 03/04/2020] [Accepted: 03/16/2020] [Indexed: 12/27/2022] Open
Abstract
Capping protein regulator and myosin 1 linker 2 (CARMIL2) deficiency is characterized by impaired T cell activation, which is attributed to defective CD28-mediated co-signaling. Herein, we aimed to analyze the effect of exogenous interleukin (IL)-2 on in-vitro T cell activation and proliferation in a family with CARMIL2 deficiency. This study included four children (one male and three females; aged 2·5-10 years at presentation). The patients presented with inflammatory bowel disease and recurrent viral infections. Genetic analysis revealed a novel homozygous 25-base pairs deletion in CARMIL2. Immunoblotting demonstrated the absence of CARMIL2 protein in all four patients and confirmed the diagnosis of CARMIL2 deficiency. T cells were activated in-vitro with the addition of IL-2 in different concentrations. CD25 and interferon (IFN)-γ levels were measured after 48 h and 5 days of activation. CD25 surface expression on activated CD8+ and CD4+ T cells was significantly diminished in all patients compared to healthy controls. Additionally, CD8+ T cells from all patients demonstrated significantly reduced IFN-γ production. When cells derived from CARMIL2-deficient patients were treated with IL-2, CD25 and IFN-γ production increased in a dose-dependent manner. T cell proliferation, as measured by Cell Trace Violet, was impaired in one patient and it was also rescued with IL-2. In conclusion, we found that IL-2 rescued T cell activation and proliferation in CARMIL2-deficient patients. Thus, IL-2 should be further studied as a potential therapeutic modality for these patients.
Collapse
Affiliation(s)
- O Shamriz
- The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.,Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | - A J Simon
- Sheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, Ramat-Gan, Israel
| | - A Lev
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.,Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Affiliated with Tel Aviv University, Tel Aviv, Israel
| | - O Megged
- Pediatric Infectious diseases Unit, Shaare Zedek Medical Center, Jerusalem, Israel
| | - O Ledder
- Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, Jerusalem, Israel
| | - E Picard
- Pediatric pulmonology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
| | - L Joseph
- Pediatric pulmonology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
| | - V Molho-Pessach
- Department of Dermatology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | - Y Tal
- Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | - P Millman
- Pediatric Gastroenterology Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | - M Slae
- Pediatric Gastroenterology Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | - R Somech
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.,Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Affiliated with Tel Aviv University, Tel Aviv, Israel
| | - O Toker
- Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.,Allergy and Clinical Immunology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
| | - M Berger
- The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel
| |
Collapse
|
11
|
Sitilertpisan P, Joseph L, Paungmali A, Paungmali U, Chunchai T. Investigation of the Contraction Ratio of Transversus Abdominis and Internal Oblique Muscles during Lumbopelvic Stability Test. Muscles Ligaments Tendons J 2020. [DOI: 10.32098/mltj.01.2020.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- P. Sitilertpisan
- Department of Physical Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai, Thailand
| | - L. Joseph
- School of Health Science, University of Brighton, East Sussex, United Kingdom
| | - A. Paungmali
- Department of Physical Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai, Thailand
| | - U. Paungmali
- Department of Physical Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Chiangmai, Thailand
| | - T. Chunchai
- Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiangmai, Thailand
| |
Collapse
|
12
|
Bougouin W, Dumas F, Lamhaut L, Marijon E, Carli P, Combes A, Pirracchio R, Aissaoui N, Karam N, Deye N, Sideris G, Beganton F, Jost D, Cariou A, Jouven X, Adnet F, Agostinucci JM, Aissaoui-Balanant N, Algalarrondo V, Alla F, Alonso C, Amara W, Annane D, Antoine C, Aubry P, Azoulay E, Beganton F, Benhamou D, Billon C, Bougouin W, Boutet J, Bruel C, Bruneval P, Cariou A, Carli P, Casalino E, Cerf C, Chaib A, Cholley B, Cohen Y, Combes A, Crahes M, Da Silva D, Das V, Demoule A, Denjoy I, Deye N, Dhonneur G, Diehl JL, Dinanian S, Domanski L, Dreyfuss D, Duboc D, Dubois-Rande JL, Dumas F, Empana JP, Extramiana F, Fartoukh M, Fieux F, Gabbas M, Gandjbakhch E, Geri G, Guidet B, Halimi F, Henry P, Hidden Lucet F, Jabre P, Jacob L, Joseph L, Jost D, Jouven X, Karam N, Kassim H, Lacotte J, Lahlou-Laforet K, Lamhaut L, Lanceleur A, Langeron O, Lavergne T, Lecarpentier E, Leenhardt A, Lellouche N, Lemiale V, Lemoine F, Linval F, Loeb T, Ludes B, Luyt CE, Maltret A, Mansencal N, Mansouri N, Marijon E, Marty J, Maury E, Maxime V, Megarbane B, Mekontso-Dessap A, Mentec H, Mira JP, Monnet X, Narayanan K, Ngoyi N, Perier MC, Piot O, Pirracchio R, Plaisance P, Plu I, Raux M, Revaux F, Ricard JD, Richard C, Riou B, Roussin F, Santoli F, Schortgen F, Sharifzadehgan A, Sideris G, Spaulding C, Teboul JL, Timsit JF, Tourtier JP, Tuppin P, Ursat C, Varenne O, Vieillard-Baron A, Voicu S, Wahbi K, Waldmann V. Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study. Eur Heart J 2019; 41:1961-1971. [DOI: 10.1093/eurheartj/ehz753] [Citation(s) in RCA: 98] [Impact Index Per Article: 19.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Revised: 03/26/2019] [Accepted: 10/01/2019] [Indexed: 11/13/2022] Open
Abstract
Abstract
Aims
Out-of-hospital cardiac arrest (OHCA) without return of spontaneous circulation (ROSC) despite conventional resuscitation is common and has poor outcomes. Adding extracorporeal membrane oxygenation (ECMO) to cardiopulmonary resuscitation (extracorporeal-CPR) is increasingly used in an attempt to improve outcomes.
Methods and results
We analysed a prospective registry of 13 191 OHCAs in the Paris region from May 2011 to January 2018. We compared survival at hospital discharge with and without extracorporeal-CPR and identified factors associated with survival in patients given extracorporeal-CPR. Survival was 8% in 525 patients given extracorporeal-CPR and 9% in 12 666 patients given conventional-CPR (P = 0.91). By adjusted multivariate analysis, extracorporeal-CPR was not associated with hospital survival [odds ratio (OR), 1.3; 95% confidence interval (95% CI), 0.8–2.1; P = 0.24]. By conditional logistic regression with matching on a propensity score (including age, sex, occurrence at home, bystander CPR, initial rhythm, collapse-to-CPR time, duration of resuscitation, and ROSC), similar results were found (OR, 0.8; 95% CI, 0.5–1.3; P = 0.41). In the extracorporeal-CPR group, factors associated with hospital survival were initial shockable rhythm (OR, 3.9; 95% CI, 1.5–10.3; P = 0.005), transient ROSC before ECMO (OR, 2.3; 95% CI, 1.1–4.7; P = 0.03), and prehospital ECMO implantation (OR, 2.9; 95% CI, 1.5–5.9; P = 0.002).
Conclusions
In a population-based registry, 4% of OHCAs were treated with extracorporeal-CPR, which was not associated with increased hospital survival. Early ECMO implantation may improve outcomes. The initial rhythm and ROSC may help select patients for extracorporeal-CPR.
Collapse
Affiliation(s)
- Wulfran Bougouin
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Medical-Surgical Intensive Care Unit, Ramsay Générale de Santé, Hôpital Privé Jacques Cartier, 6 Avenue du Noyer Lambert, 91300 Massy, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- AfterROSC network, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France
| | - Florence Dumas
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Emergency Department, Cochin-Hotel-Dieu Hospital, APHP, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France
| | - Lionel Lamhaut
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- AfterROSC network, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Intensive Care Unit - SAMU 75, Necker-Enfants-Malades Hospital, APHP, 149 Rue de Sèvres, 75015 Paris, France
| | - Eloi Marijon
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Cardiology Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
| | - Pierre Carli
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Intensive Care Unit - SAMU 75, Necker-Enfants-Malades Hospital, APHP, 149 Rue de Sèvres, 75015 Paris, France
| | - Alain Combes
- Medical-Surgical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, Pitié-Salpétrière Hospital, APHP, 47-83 Boulevard de l'Hôpital, 75013 Paris, France
| | - Romain Pirracchio
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Surgical ICU, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
| | - Nadia Aissaoui
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- AfterROSC network, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Medical ICU, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
| | - Nicole Karam
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Cardiology Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
| | - Nicolas Deye
- AfterROSC network, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France
- Medical ICU, Lariboisière Hospital, AP-HP, 2 Rue Ambroise Paré, 75010 Paris, France
| | - Georgios Sideris
- Cardiology Department, Lariboisière Hospital, AP-HP, 2 Rue Ambroise Paré, 75010 Paris, France
| | - Frankie Beganton
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
| | - Daniel Jost
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- Brigade de Sapeurs Pompiers de Paris (BSPP), 1 Place Jules Renard, 75017 Paris, France
| | - Alain Cariou
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- AfterROSC network, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Medical Intensive Care Unit, Cochin Hospital, APHP, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France
| | - Xavier Jouven
- Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, 56 rue Leblanc, 75787 Paris, France
- Paris Sudden Death Expertise Center, 56 rue Leblanc, 75787 Paris, France
- Université Paris Descartes-Sorbonne Paris Cité, 12 Rue de l'École de Médecine, 75006 Paris, France
- Cardiology Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Sanmamed N, Glicksman R, Heaton J, Herrera-Caceres J, Joseph L, Hansen A, Chung P, Finelli A, Fleshner N, Berlin A. Use of Combined Hormone Therapy with Post-Operative Radiation Treatment for Prostate Cancer: Impact of Randomized Trials On Clinical Practice. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
14
|
Hopman WM, Berger C, Joseph L, Morin SN, Towheed T, Anastassiades T, Adachi JD, Hanley DA, Prior JC, Goltzman D. Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study. Osteoporos Int 2019; 30:1635-1644. [PMID: 31069440 DOI: 10.1007/s00198-019-05000-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2019] [Accepted: 04/22/2019] [Indexed: 01/22/2023]
Abstract
UNLABELLED Little is known about the association between health-related quality of life (HRQOL) and osteoporosis in the absence of fracture, and how HRQOL may change over time. This study provides evidence of substantially reduced HRQOL in women and men with self-reported and/or BMD-confirmed osteoporosis, even in the absence of fragility fracture. INTRODUCTION Fragility fractures have a detrimental effect on the health-related quality of life (HRQOL) of those with osteoporosis. Less is known about the association between HRQOL and osteoporosis in the absence of fracture. METHODS Canadian Multicentre Osteoporosis Study participants completed the SF-36, a detailed health questionnaire and measures of bone mineral density (BMD) at baseline and follow-up. We report the results of participants ≥ 50 years with 10-year follow-up. Self-reported osteoporosis at baseline and BMD-based osteoporosis at follow-up were ascertained. Multivariable linear regression models were developed for baseline SF-36 domains, component summaries, and change over time, adjusting for relevant baseline information. RESULTS Baseline data were available for 5266 women and 2112 men. Women in the osteoporosis group had substantially lower SF-36 baseline scores, particularly in the physically oriented domains, than those without osteoporosis. A similar but attenuated pattern was evident for the men. After 10-year follow-up (2797 women and 1023 men), most domain scores dropped for women and men regardless of osteoporosis status, with the exception of mentally-oriented ones. In general, a fragility fracture was associated with lower SF-36 scores and larger declines over time. CONCLUSIONS This study provides evidence of substantially reduced HRQOL in women and men with self-reported and/or BMD-confirmed osteoporosis, even in the absence of fragility fracture. HRQOL should be thoroughly investigated even prior to fracture, to develop appropriate interventions for all stages of the disease.
Collapse
Affiliation(s)
- W M Hopman
- Kingston General Health Research Institute, Kingston Health Sciences Centre, Kingston, Ontario, Canada.
- Department of Public Health Sciences, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada.
| | - C Berger
- Research Institute of the McGill University Health Centre, Montreal, QC, Canada
| | - L Joseph
- Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada
| | - S N Morin
- Department of Medicine, McGill University, Montréal, QC, Canada
| | - T Towheed
- Division of Rheumatology, Department of Medicine, Queen's University, Kingston, ON, Canada
| | - T Anastassiades
- Division of Rheumatology, Department of Medicine, Queen's University, Kingston, ON, Canada
| | - J D Adachi
- Department of Medicine, McMaster University, Hamilton, ON, Canada
| | - D A Hanley
- McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, AB, Canada
| | - J C Prior
- Department of Medicine/Endocrinology, University of British Columbia, Vancouver, BC, Canada
| | - D Goltzman
- Department of Medicine, McGill University, Montréal, QC, Canada
| | | |
Collapse
|
15
|
Honsel V, Khimoud D, Ranque B, Offredo L, Joseph L, Pouchot J, Arlet J. Différences phénotypiques entre patients drépanocytaires adultes d’origine sub-Saharienne nés en France métropolitaine et nés en Afrique sub-Saharienne. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
16
|
Joseph L, Sundaramurthy A, Berlin A, Helou J, Menard C, Warde P, Catton C, Lao B, Bayley A, Rink A, Beiki-Ardakani A, Chung P. PV-0147 MRI-guided salvage HDR brachytherapy for locally recurrent prostate cancer. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30567-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
17
|
Khan Z, Ahmad S, Jeragh A, Alfouzan W, Al Foudri H, Hassan N, Asadzadeh M, Joseph L, Varghese S. First isolation of Ascotricha chartarum from bronchoalveolar lavage of two patients with pulmonary infections. New Microbes New Infect 2018; 28:11-16. [PMID: 30766685 PMCID: PMC6363919 DOI: 10.1016/j.nmni.2018.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2018] [Revised: 12/18/2018] [Accepted: 12/19/2018] [Indexed: 11/12/2022] Open
Abstract
Ascotricha chartarum is a rare human pathogen. We describe the isolation and characterization of A. chartarum from bronchoalveolar lavage samples of two patients with underlying pulmonary infections. The identity of both isolates was established by typical phenotypic characteristics and by sequencing of the internal transcribed spacer region and D1/D2 domains of recombinant DNA and β-tubulin gene fragment. The demonstration of branched, septate hyphae in direct microscopic examination of both the specimens and isolation of the fungus in pure cultures suggest its aetiologic role in the disease process. Because of phenotypic similarities of A. chartarum with Chaetomium spp. and other Chaetomium-like fungi, the application of molecular methods is needed for its accurate identification. Although in the absence of histopathologic evidence the aetiologic role of A. chartarum could not be established unequivocally, nonetheless, in view of the rarity of its isolation from clinical specimens and demonstration of hyphal elements in bronchoalveolar lavage sample, this report assumes considerable significance. It serves to create awareness about environmental fungi that previously have missed attention but may play a role in respiratory infections.
Collapse
Affiliation(s)
- Z Khan
- Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
| | - S Ahmad
- Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
| | - A Jeragh
- Department of Microbiology, , Al Adan Hospital, Kuwait
| | - W Alfouzan
- Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
| | - H Al Foudri
- Critical Care and ECMO Unit, Anesthesia Department, Al Adan Hospital, Kuwait
| | - N Hassan
- Department of Microbiology, , Al Adan Hospital, Kuwait
| | - M Asadzadeh
- Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
| | - L Joseph
- Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
| | - S Varghese
- Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
| |
Collapse
|
18
|
Jeragh A, Ahmad S, Khan Z, Tarazi RY, Ajmi S, Joseph L, Varghese S, Vayalil S. Subcutaneous phaeohyphomycosis caused by Amesia atrobrunnea in Kuwait. J Mycol Med 2018; 29:193-197. [PMID: 30446389 DOI: 10.1016/j.mycmed.2018.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2018] [Revised: 09/10/2018] [Accepted: 10/29/2018] [Indexed: 11/26/2022]
Abstract
The recently described genus Amesia encompasses four species but only Amesia atrobrunnea (=Chaetomium atrobrunneum) is known to be pathogenic to humans. Here, we describe a case of subcutaneous phaeohyphomycosis in Kuwait in an apparently immunocompetent patient diagnosed by direct microscopy of the infected tissue and culture. The identity of A. atrobrunnea was established by typical morphological characteristics and by sequencing of internally transcribed spacer (ITS) region and D1/D2 domains of rDNA. To the best of our knowledge, this is the first report documenting etiologic role of this species in causing a locally invasive subcutaneous infection.
Collapse
Affiliation(s)
- A Jeragh
- Departments of Microbiology, Al Adan Hospital, Kuwait
| | - S Ahmad
- Department of Microbiology, Kuwait
| | - Z Khan
- Department of Microbiology, Kuwait; Mycology Reference Laboratory, Faculty of Medicine, Kuwait University, Kuwait.
| | - R Y Tarazi
- Cardiac surgery, Al Adan Hospital, Kuwait
| | - S Ajmi
- Departments of Microbiology, Al Adan Hospital, Kuwait
| | - L Joseph
- Department of Microbiology, Kuwait
| | | | - S Vayalil
- Mycology Reference Laboratory, Faculty of Medicine, Kuwait University, Kuwait
| |
Collapse
|
19
|
Affiliation(s)
- L Joseph
- Imperial College London, London, UK
| | - S Ismail
- Imperial College London, London, UK
| | | | - M Gunst
- Sydney Children's Hospital Network, Sydney, Australia
| | | | - M Harris
- Imperial College London, London, UK
| | - A Abbara
- Imperial College London, London, UK
| |
Collapse
|
20
|
Parikh S, Murray L, Kenning L, Bottomley D, Din O, Dixit S, Ferguson C, Handforth C, Joseph L, Mokhtar D, White L, Wright G, Henry A. Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer. Clin Oncol (R Coll Radiol) 2018; 30:548-555. [DOI: 10.1016/j.clon.2018.06.004] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2018] [Revised: 05/16/2018] [Accepted: 05/20/2018] [Indexed: 01/04/2023]
|
21
|
Sanchez-Villavicencio ML, Elamer N, Joseph L, Saleem A, Hall B, Harris CS, Cuerrier A, Arnason JT, Haddad PS. Non-polar solvent fractions of Oplopanax horridus stimulate muscle glucose uptake and inhibit hepatocellular glucose-6-phosphatase enzyme activity. Am J Transl Res 2018. [DOI: 10.1055/s-0038-1644932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- ML Sanchez-Villavicencio
- CIHR Team in Aboriginal Antidiabetic Medicines
- Département de pharmacologie et physiologie, Université de Montréal, Montréal, QUEBEC, Canada
| | - N Elamer
- CIHR Team in Aboriginal Antidiabetic Medicines
- Département de pharmacologie et physiologie, Université de Montréal, Montréal, QUEBEC, Canada
| | - L Joseph
- CIHR Team in Aboriginal Antidiabetic Medicines
- Département de sciences biologiques, Université de Montréal, Montréal, QUEBEC, Canada
| | - A Saleem
- CIHR Team in Aboriginal Antidiabetic Medicines
- Department of Biology, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
| | - B Hall
- CIHR Team in Aboriginal Antidiabetic Medicines
- Department of Biology, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
| | - CS Harris
- CIHR Team in Aboriginal Antidiabetic Medicines
- Department of Biology, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
| | - A Cuerrier
- CIHR Team in Aboriginal Antidiabetic Medicines
- Département de sciences biologiques, Université de Montréal, Montréal, QUEBEC, Canada
| | - JT Arnason
- CIHR Team in Aboriginal Antidiabetic Medicines
- Department of Biology, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
| | - PS Haddad
- CIHR Team in Aboriginal Antidiabetic Medicines
- Département de pharmacologie et physiologie, Université de Montréal, Montréal, QUEBEC, Canada
| |
Collapse
|
22
|
Salem A, Gorman D, Mistry H, Joseph L, Shah R, Valentine H, Jackson A, West C, Faivre-Finn C, O'Connor J, Asselin M. OC-0267: Technical and biological validation of hypoxia PET imaging using [18F]fluroazomycin (FAZA) in NSCLC. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)30577-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
23
|
Cessna JT, Fitzgerald R, Zimmerman BE, Laureano-Pérez L, Bergeron DE, van Wyngaardt F, Smith M, Jackson T, Howe B, da Silva CJ, Iwahara A, da Cruz PAL, Zhang M, Liu H, Liang J, Fréchou C, Bobin C, Cassette P, Kossert K, Nähle O, Marganiec-Gałązka J, Joseph L, Ravindra A, Kulkarni DN, Yunoki A, Sato Y, Lee KB, Lee JM, Agung, Dziel T, Listkowska A, Tymiński Z, Sahagia M, Antohe A, Ioan MR, Luca A, Krivosek M, Ometakova J, Javornik A, Zalesakova M, García-Toraño Martinez E, Roteta M, Mejuto M, Nedjadi Y, Juget F, Yuan MC, Yeh CY, Yeltepe E, Dirican A, Keightley J, Pearce A. Results of an international comparison of activity measurements of 68Ge. Appl Radiat Isot 2018; 134:385-390. [PMID: 29248210 PMCID: PMC10996930 DOI: 10.1016/j.apradiso.2017.10.052] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2017] [Revised: 10/30/2017] [Accepted: 10/30/2017] [Indexed: 11/25/2022]
Abstract
An international key comparison, identifier CCRI(II)-K2.Ge-68, has been performed. The National Institute of Standards and Technology (NIST) served as the pilot laboratory, distributing aliquots of a 68Ge/68Ga solution. Results for the activity concentration, CA, of 68Ge at a reference date of 12h00 UTC 14 November 2014 were submitted by 17 laboratories, encompassing many variants of coincidence methods and liquid-scintillation counting methods. The first use of 4π(Cherenkov)β-γ coincidence and anticoincidence methods in an international comparison is reported. One participant reported results by secondary methods only. Two results, both utilizing pure liquid-scintillation methods, were identified as outliers. Evaluation using the Power-Moderated Mean method results in a proposed Comparison Reference Value (CRV) of 621.7(11)kBqg-1, based on 14 results. The degrees of equivalence and their associated uncertainties are evaluated for each participant. Several participants submitted 3.6mL ampoules to the BIPM to link the comparison to the International Reference System (SIR) which may lead to the evaluation of a Key Comparison Reference Value and associated degrees of equivalence.
Collapse
Affiliation(s)
- J T Cessna
- Physical Measurements Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA.
| | - R Fitzgerald
- Physical Measurements Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA
| | - B E Zimmerman
- Physical Measurements Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA
| | - L Laureano-Pérez
- Physical Measurements Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA
| | - D E Bergeron
- Physical Measurements Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA
| | - F van Wyngaardt
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - M Smith
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - T Jackson
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - B Howe
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - C J da Silva
- Laboratório Nacional de Metrologia das Radiações Ionizantes, Instituto de Radioproteção e Dosimetria, Rio de Janeiro, Brazil
| | - A Iwahara
- Laboratório Nacional de Metrologia das Radiações Ionizantes, Instituto de Radioproteção e Dosimetria, Rio de Janeiro, Brazil
| | - P A L da Cruz
- Laboratório Nacional de Metrologia das Radiações Ionizantes, Instituto de Radioproteção e Dosimetria, Rio de Janeiro, Brazil
| | - M Zhang
- National Institute of Metrology, Beijing, China
| | - H Liu
- National Institute of Metrology, Beijing, China
| | - J Liang
- National Institute of Metrology, Beijing, China
| | - C Fréchou
- Laboratoire national de métrologie et d'essais - Laboratoire national Henri Becquerel, Gif-sur-Yvette cedex, France
| | - C Bobin
- Laboratoire national de métrologie et d'essais - Laboratoire national Henri Becquerel, Gif-sur-Yvette cedex, France
| | - P Cassette
- Laboratoire national de métrologie et d'essais - Laboratoire national Henri Becquerel, Gif-sur-Yvette cedex, France
| | - K Kossert
- Physikalisch-Technische Bundesanstalt, Braunschweig, Germany
| | - O Nähle
- Physikalisch-Technische Bundesanstalt, Braunschweig, Germany
| | | | - L Joseph
- Bhabha Atomic Research Centre, Mumbai, India
| | - A Ravindra
- Bhabha Atomic Research Centre, Mumbai, India
| | | | - A Yunoki
- National Metrology Institute of Japan, AIST, Tsukuba, Japan
| | - Y Sato
- National Metrology Institute of Japan, AIST, Tsukuba, Japan
| | - K B Lee
- Korea Research Institute of Standards and Science, Daejeon, Republic of Korea
| | - J M Lee
- Korea Research Institute of Standards and Science, Daejeon, Republic of Korea
| | - Agung
- Korea Research Institute of Standards and Science, Daejeon, Republic of Korea
| | - T Dziel
- National Centre for Nuclear Research Radioisotope Centre POLATOM, Otwock, Poland
| | - A Listkowska
- National Centre for Nuclear Research Radioisotope Centre POLATOM, Otwock, Poland
| | - Z Tymiński
- National Centre for Nuclear Research Radioisotope Centre POLATOM, Otwock, Poland
| | - M Sahagia
- National Institute of Research and Development for Physics and Nuclear Engineering "Horia Hulubei", Bucarest - Magurele, Romania
| | - A Antohe
- National Institute of Research and Development for Physics and Nuclear Engineering "Horia Hulubei", Bucarest - Magurele, Romania
| | - M-R Ioan
- National Institute of Research and Development for Physics and Nuclear Engineering "Horia Hulubei", Bucarest - Magurele, Romania
| | - A Luca
- National Institute of Research and Development for Physics and Nuclear Engineering "Horia Hulubei", Bucarest - Magurele, Romania
| | - M Krivosek
- Slovenský Metrologický Ústav, Bratislava, Slovakia
| | - J Ometakova
- Slovenský Metrologický Ústav, Bratislava, Slovakia
| | - A Javornik
- Slovenský Metrologický Ústav, Bratislava, Slovakia
| | - M Zalesakova
- Slovenský Metrologický Ústav, Bratislava, Slovakia
| | | | - M Roteta
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain
| | - M Mejuto
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain
| | - Y Nedjadi
- Institut Universitaire de Radiophysique Appliquée, Lausanne, Switzerland
| | - F Juget
- Institut Universitaire de Radiophysique Appliquée, Lausanne, Switzerland
| | - M-C Yuan
- Institute of Nuclear Energy Research, Taoyuan County, Taiwan
| | - C Y Yeh
- Institute of Nuclear Energy Research, Taoyuan County, Taiwan
| | - E Yeltepe
- Turkish Atomic Energy Authority, Lodumlu - Ankara, Turkey
| | - A Dirican
- Turkish Atomic Energy Authority, Lodumlu - Ankara, Turkey
| | - J Keightley
- National Physical Laboratory, Teddington, United Kingdom
| | - A Pearce
- National Physical Laboratory, Teddington, United Kingdom
| |
Collapse
|
24
|
Affiliation(s)
- B G Baker
- 1 Department of Burns & Plastic Surgery, University Hospital South Manchester, Wythenshawe, UK
| | - L Joseph
- 2 Department of Pathology, University Hospital South Manchester, Wythenshawe, UK
| | - A Mishra
- 1 Department of Burns & Plastic Surgery, University Hospital South Manchester, Wythenshawe, UK
| |
Collapse
|
25
|
Shah B, Preset I, Basnet M, Joseph L, Bishop P, Quinn A. 42: An audit of the frequency of immunochemical expression of CDX2 within lung carcinomas. Lung Cancer 2017. [DOI: 10.1016/s0169-5002(17)30092-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
26
|
Basnet M, Quinn A, Noor H, Rana D, Thiryayi S, Shelton D, Al-Habba S, Narine N, McGrath S, Chandran U, Doran H, Joseph L, Bishop P, Chaturvedi A, Ganjifrockwala A, Paiva-Correia A, Saravana R, Nasir N, Nonaka D, Wallace A, Crosbie P, Bayman N, Blackhall F. 53: A survey of regional practice affecting small sample diagnosis and tissue managment of lung carcinoma samples, with development of a local guideline. Lung Cancer 2017. [DOI: 10.1016/s0169-5002(17)30103-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
27
|
Larivée N, Suissa S, Eberg M, Joseph L, Eisenberg MJ, Abenhaim HA, Filion KB. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study. BJOG 2016; 124:1672-1679. [DOI: 10.1111/1471-0528.14358] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/16/2016] [Indexed: 11/29/2022]
Affiliation(s)
- N Larivée
- Center for Clinical Epidemiology; Lady Davis Institute; Jewish General Hospital; Montreal Quebec Canada
- Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal Quebec Canada
| | - S Suissa
- Center for Clinical Epidemiology; Lady Davis Institute; Jewish General Hospital; Montreal Quebec Canada
- Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal Quebec Canada
- Division of Clinical Epidemiology; Department of Medicine; McGill University; Montreal Quebec Canada
| | - M Eberg
- Center for Clinical Epidemiology; Lady Davis Institute; Jewish General Hospital; Montreal Quebec Canada
| | - L Joseph
- Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal Quebec Canada
- Division of Clinical Epidemiology; McGill University Health Centre; Montreal Quebec Canada
| | - MJ Eisenberg
- Center for Clinical Epidemiology; Lady Davis Institute; Jewish General Hospital; Montreal Quebec Canada
- Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal Quebec Canada
- Division of Cardiology; Jewish General Hospital; McGill University; Montreal Quebec Canada
| | - HA Abenhaim
- Center for Clinical Epidemiology; Lady Davis Institute; Jewish General Hospital; Montreal Quebec Canada
- Department of Obstetrics and Gynecology; Jewish General Hospital; McGill University; Montreal Quebec Canada
| | - KB Filion
- Center for Clinical Epidemiology; Lady Davis Institute; Jewish General Hospital; Montreal Quebec Canada
- Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal Quebec Canada
- Division of Clinical Epidemiology; Department of Medicine; McGill University; Montreal Quebec Canada
| |
Collapse
|
28
|
Lowensteyn I, Berberian V, Joseph L, Belisle P, Grover S. USING THE WORKPLACE TO OPTIMIZE HEART HEALTH. THE 1-YEAR RESULTS OF THE MERCK CANADA EMPLOYEE WELLNESS PROGRAM. Can J Cardiol 2016. [DOI: 10.1016/j.cjca.2016.07.389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
29
|
Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PR, Ginzler E, Romero-Diaz J, Peschken C, Jacobsen S, Hanly JG, Gordon C, Nived O, Yelin EH, Isenberg D, Rahman A, Bae SC, Joseph L, Witte T, Ruiz-Irastorza G, Aranow C, Kamen D, Sturfeldt G, Foulkes WD, Hansen JE, St Pierre Y, Raymer PC, Tessier-Cloutier B, Clarke AE. Breast cancer in systemic lupus. Lupus 2016; 26:311-315. [PMID: 27687028 DOI: 10.1177/0961203316664595] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Objective There is a decreased breast cancer risk in systemic lupus erythematosus (SLE) versus the general population. We assessed a large sample of SLE patients, evaluating demographic and clinical characteristics and breast cancer risk. Methods We performed case-cohort analyses within a multi-center international SLE sample. We calculated the breast cancer hazard ratio (HR) in female SLE patients, relative to demographics, reproductive history, family history of breast cancer, and time-dependent measures of anti-dsDNA positivity, cumulative disease activity, and drugs, adjusted for SLE duration. Results There were 86 SLE breast cancers and 4498 female SLE cancer-free controls. Patients were followed on average for 7.6 years. Versus controls, SLE breast cancer cases tended to be white and older. Breast cancer cases were similar to controls regarding anti-dsDNA positivity, disease activity, and most drug exposures over time. In univariate and multivariate models, the principal factor associated with breast cancers was older age at cohort entry. Conclusions There was little evidence that breast cancer risk in this SLE sample was strongly driven by any of the clinical factors that we studied. Further search for factors that determine the lower risk of breast cancer in SLE may be warranted.
Collapse
Affiliation(s)
- S Bernatsky
- 1 Faculty of Medicine, McGill University, Montreal, Canada.,2 Division of Clinical Epidemiology, Research Institute of the McGill University Health Center, Montreal, Canada
| | - R Ramsey-Goldman
- 3 Feinberg School of Medicine, Northwestern University, Chicago, USA
| | - M Petri
- 4 Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, USA
| | - M B Urowitz
- 5 Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Canada
| | - D D Gladman
- 5 Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Canada
| | - P R Fortin
- 6 Division of Rheumatology, Centre de recherche du CHU de Québec-Université Laval, Quebec City, Canada
| | - E Ginzler
- 7 State University of New York-Downstate Medical Center, New York, USA
| | - J Romero-Diaz
- 8 Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico
| | - C Peschken
- 9 University of Manitoba, Winnipeg, Canada
| | - S Jacobsen
- 10 Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
| | - J G Hanly
- 11 Division of Rheumatology, Dalhousie University and Nova Scotia Health Authority, Halifax, Canada
| | - C Gordon
- 12 Rheumatology Research Group, Institute for Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham: Rheumatology department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust and NIHR/Wellcome Trust Clinical Research Facility, Queen Elizabeth Hospital Birmingham; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
| | - O Nived
- 13 Department of Rheumatology, Institution of Clinical Sciences, Lund University Hospital, Lund, Sweden
| | - E H Yelin
- 14 Department of Medicine, University of California, San Francisco, USA
| | - D Isenberg
- 15 Centre for Rheumatology Research, University College London, London, UK
| | - A Rahman
- 15 Centre for Rheumatology Research, University College London, London, UK
| | - S-C Bae
- 16 The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea
| | - L Joseph
- 1 Faculty of Medicine, McGill University, Montreal, Canada.,2 Division of Clinical Epidemiology, Research Institute of the McGill University Health Center, Montreal, Canada
| | - T Witte
- 17 Department of Clinical Immunology, Hannover Medical School, Hannover, Germany
| | - G Ruiz-Irastorza
- 18 Autoimmune Diseases Research Unit, Department Of Internal Medicine, Hospital Universitario Cruces, University Of The Basque Country, Bizkaia, Spain
| | - C Aranow
- 19 Feinstein Institute for Medical Research, New York, USA
| | - D Kamen
- 20 Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, USA
| | - G Sturfeldt
- 13 Department of Rheumatology, Institution of Clinical Sciences, Lund University Hospital, Lund, Sweden
| | - W D Foulkes
- 21 Departments of Oncology, Human Genetics and Medicine, McGill University, Montreal, Canada
| | - J E Hansen
- 22 Department of Therapeutic Radiology, Yale School of Medicine, New Haven, USA
| | - Y St Pierre
- 2 Division of Clinical Epidemiology, Research Institute of the McGill University Health Center, Montreal, Canada
| | - P Chrétien Raymer
- 2 Division of Clinical Epidemiology, Research Institute of the McGill University Health Center, Montreal, Canada
| | - B Tessier-Cloutier
- 23 Department of Anatomical Pathology, University of British Colombia, Vancouver, Canada
| | - A E Clarke
- 24 Division of Rheumatology, University of Calgary, Calgary, Canada
| |
Collapse
|
30
|
Vignier N, Faure Grise D, Jeannerod V, Verdavaine G, Joseph L, Diamantis S, Binart M. MIG-02 - Pathologies infectieuses rencontrées dans une consultation d’accès aux soins et aux droits. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30445-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Joseph L, Jeanmonod R, Jeanmonod D. 294 A Comparison of Ultrasound-Guided and Palpation-Guided Identification of Lumbar Puncture Needle Entry Site in Patients as Body Mass Index Increases. Ann Emerg Med 2015. [DOI: 10.1016/j.annemergmed.2015.07.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
32
|
Joseph L, Paul H, Premkumar J, Paul R, Michael JS. Biomedical waste management: study on the awareness and practice among healthcare workers in a tertiary teaching hospital. Indian J Med Microbiol 2015; 33:129-31. [PMID: 25560016 DOI: 10.4103/0255-0857.148411] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Bio-medical waste has a higher potential of infection and injury to the healthcare worker, patient and the surrounding community. Awareness programmes on their proper handling and management to healthcare workers can prevent the spread of infectious diseases and epidemics. This study was conducted in a tertiary care hospital to assess the impact of training, audits and education/implementations from 2009 to 2012 on awareness and practice of biomedical waste segregation. Our study reveals focused training, strict supervision, daily surveillance, audits inspections, involvement of hospital administrators and regular appraisals are essential to optimise the segregation of biomedical waste.
Collapse
Affiliation(s)
| | | | | | | | | | - J S Michael
- Department of Clinical Microbiology , Christian Medical College and Hospital, Vellore, Tamil Nadu, India
| |
Collapse
|
33
|
Lane N, Lahham S, Joseph L, Bahner DP, Fox JC. Ultrasound in medical education: listening to the echoes of the past to shape a vision for the future. Eur J Trauma Emerg Surg 2015; 41:461-7. [PMID: 26038053 DOI: 10.1007/s00068-015-0535-7] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2015] [Accepted: 04/18/2015] [Indexed: 01/16/2023]
Abstract
PURPOSE Ultrasound in medical education has seen a tremendous growth over the last 10-20 years but ultrasound technology has been around for hundreds of years and sound has an even longer scientific history. The development of using sound and ultrasound to understand our body and our surroundings has been a rich part of human history. From the development of materials to produce piezoelectric conductors, ultrasound has been used and improved in many industries and medical specialties. METHODS As diagnostic medical ultrasound has improved its resolution and become more portable, various specialties from radiology, cardiology, obstetrics and more recently emergency, critical care and proceduralists have found the added benefits of using ultrasound to safely help patients. The past advancements in technology have established the scaffold for the possibilities of diagnostic ultrasound's use in the present and future. RESULTS A few medical educators have integrated ultrasound into medical school while a wealth of content exists online for learning ultrasound. Twenty-first century learners prefer blended learning where material can be reviewed online and personalize the education on their own time frame. This material combined with hands-on experience and mentorship can be used to develop learners' aptitude in ultrasound. CONCLUSIONS As educators embrace this ultrasound technology and integrate it throughout the medical education journey, collaboration across specialties will synthesize a clear path forward when needs and resources are paired with vision and a strategic plan.
Collapse
Affiliation(s)
- N Lane
- Irvine School of Medicine, University of California, Irvine, USA
| | - S Lahham
- Irvine School of Medicine, University of California, Irvine, USA
| | - L Joseph
- Irvine School of Medicine, University of California, Irvine, USA
| | - D P Bahner
- The Ohio State University, 756 Prior Hall, 376 W. 10th Avenue, Columbus, OH, 43210, USA.
| | - J C Fox
- Irvine School of Medicine, University of California, Irvine, USA.
| |
Collapse
|
34
|
Li Z, Stölzel F, Onel K, Sukhanova M, Mirza MK, Yap KL, Borinets O, Larson RA, Stock W, Sasaki MM, Joseph L, Raca G. Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma. Leukemia 2015; 29:2113-6. [PMID: 25787914 PMCID: PMC4575593 DOI: 10.1038/leu.2015.81] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- Z Li
- Department of Human Genetics, The University of Chicago Medical Center, Chicago, IL, USA
| | - F Stölzel
- Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany
| | - K Onel
- Department of Pediatrics, The University of Chicago Medical Center, Chicago, IL, USA
| | - M Sukhanova
- Department of Medicine, The University of Chicago Medical Center, Chicago, IL, USA
| | - M K Mirza
- Department of Pathology, The University of Chicago Medical Center, Chicago, IL, USA
| | - K L Yap
- Department of Medicine, The University of Chicago Medical Center, Chicago, IL, USA
| | - O Borinets
- Department of Medicine, The University of Chicago Medical Center, Chicago, IL, USA
| | - R A Larson
- Department of Medicine, The University of Chicago Medical Center, Chicago, IL, USA
| | - W Stock
- Department of Medicine, The University of Chicago Medical Center, Chicago, IL, USA
| | - M M Sasaki
- Department of Pediatrics, The University of Chicago Medical Center, Chicago, IL, USA
| | - L Joseph
- Department of Pathology, The University of Chicago Medical Center, Chicago, IL, USA
| | - G Raca
- Department of Medicine, The University of Chicago Medical Center, Chicago, IL, USA
| |
Collapse
|
35
|
Lavine E, Clarke A, Joseph L, Shand G, Alizadehfar R, Asai Y, Chan ES, Harada L, Allen M, Ben-Shoshan M. Peanut avoidance and peanut allergy diagnosis in siblings of peanut allergic children. Clin Exp Allergy 2014; 45:249-54. [DOI: 10.1111/cea.12403] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2014] [Revised: 08/11/2014] [Accepted: 08/18/2014] [Indexed: 11/27/2022]
Affiliation(s)
- E. Lavine
- Department of Pediatrics; Humber River Hospital; Toronto ON Canada
| | - A. Clarke
- Department of Medicine; Division of Rheumatology; University of Calgary; Calgary AB Canada
| | - L. Joseph
- Department of Medicine; Division of Clinical Epidemiology; McGill University Health Centre; Montreal QC Canada
- Department of Epidemiology and Biostatistics; McGill University; Montreal QC Canada
| | - G. Shand
- Department of Medicine; Division of Clinical Epidemiology; McGill University Health Centre; Montreal QC Canada
| | - R. Alizadehfar
- Department of Pediatrics; Division of Pediatric Allergy and Clinical Immunology; McGill University Health Centre; Montreal QC Canada
| | - Y. Asai
- Department of Medicine; Division of Dermatology; McGill University Health Centre; Montreal QC Canada
| | - E. S. Chan
- Department of Pediatrics; Division of Allergy and Immunology; University of British Columbia; Vancouver BC Canada
| | - L. Harada
- Anaphylaxis Canada; Toronto ON Canada
| | - M. Allen
- Allergy Asthma Information Association; Toronto ON Canada
| | - M. Ben-Shoshan
- Department of Pediatrics; Division of Pediatric Allergy and Clinical Immunology; McGill University Health Centre; Montreal QC Canada
| |
Collapse
|
36
|
Joseph L, Arunsasi B, Sajan D, Shettigar V. Synthesis, crystal growth, thermal, electronic and vibrational spectral studies of 1-(4-Bromophenyl)-3-(3,4-dimethoxy-phenyl)prop-2-en-1-one: A density functional theory study. J Mol Struct 2014. [DOI: 10.1016/j.molstruc.2014.08.008] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
37
|
Nicholas MK, Joseph L, Venneti S, Daher A, Pytel P. EG-08 * IDH MUTATIONS IN GLIOMAS ASSOCIATED WITH ENCHONDROMATOSIS. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou254.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Grover S, Joseph L, Kaouache M, Remple P, Lowensteyn I. CALCULATING CARDIOMETABOLIC RISK: A DISEASE SIMULATION MODEL TO ESTIMATE THE LIFETIME RISK OF COMPLICATIONS OF CARDIOVASCULAR DISEASE AND DIABETES. Can J Cardiol 2014. [DOI: 10.1016/j.cjca.2014.07.537] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
39
|
Joseph L, Casanegra AI, Dhariwal M, Smith MA, Raju MG, Militello MA, Gomes MP, Gornik HL, Bartholomew JR. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia. J Thromb Haemost 2014; 12:1044-53. [PMID: 24766902 DOI: 10.1111/jth.12592] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2014] [Accepted: 04/14/2014] [Indexed: 02/04/2023]
Abstract
BACKGROUND Heparin-induced thrombocytopenia (HIT) is an adverse immune-mediated response to unfractionated heparin and, less commonly, low molecular weight heparin. It is associated with a high thrombotic risk and the potential for limb and life-threatening complications. Argatroban is the only approved and currently available anticoagulant for HIT treatment in the USA. OBJECTIVES To report safety and efficacy outcomes with bivalirudin for HIT treatment. METHODS We retrospectively examined records from our registry of patients with a suspected, confirmed or previous history of HIT and who had received bivalirudin for anticoagulation in a single tertiary-care center over a 9-year period. RESULTS We identified 461 patients who received bivalirudin: 220 (47.7%) were surgical patients, and 241 (52.3%) were medical patients. Of this population, 107 (23.2%) were critically ill, and 109 (23.6%) were dialysis-dependent. Suspected, confirmed and previous history of HIT were reported in 262, 124 and 75 patients, respectively. Of 386 patients with suspected or confirmed HIT, 223 patients (57.8%) had thrombosis at HIT diagnosis. New thrombosis was identified in 21 patients (4.6%) while they were on treatment with therapeutic doses of bivalirudin. No patient required HIT-related amputation. Major bleeding occurred in 35 patients (7.6%). We found a significant increase in major bleeding risk in the critically ill population (13.1%; odds ratio 2.4, 95% confidence interval 1.2-4.9, P = 0.014). The 30-day all-cause mortality rate was 14.5% (67 patients), and eight of 67 (1.7%) deaths were HIT-related. CONCLUSION Bivalirudin may be an effective and safe alternative option for the treatment of both suspected and confirmed HIT, and appears to reduce the rate of HIT-related amputation.
Collapse
Affiliation(s)
- L Joseph
- Division of Cardiovascular Diseases, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Evison M, Crosbie P, Martin J, Bishop P, Doran H, Joseph L, Chaturvedi A, Barber P, Booton R. 52 EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes. Lung Cancer 2014. [DOI: 10.1016/s0169-5002(14)70052-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
41
|
Wakil S, Filion K, Atallah R, Genest J, Joseph L, Poirier P, Rinfret S, Schiffrin E, Eisenberg M. A Systematic Review of the Long-Term Effects of Popular Diets on Weight Loss and Cardiovascular Risk Factors. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
42
|
Farina S, Blom K, Haydee-Gomez Y, Cloutier L, Gelfer M, Dawes M, McKay D, Bolli P, McLean D, Hemmelgarn B, Joseph L, Bartlett G, Tobe S, Campbell N, Daskalopoulou S. Measurebp: Identifying Evidence-Based Threshold and Target Values for Newer Automated Methods of Measuring Blood Pressure. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
43
|
Shimony A, Grandi S, Pilote L, Joseph L, O'Loughlin J, Paradis G, Rinfret S, Sarrafzadegan N, Adamjee N, Yadav R, Gamra H, Eisenberg M. Utilization of Evidence-Based Therapy for Acute Coronary Syndrome in High Income and Middle/Low Income Countries. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
44
|
Zhang D, Eisenberg M, Grandi S, Joseph L, Pilote L, Filion K. Bupropion, Smoking Cessation, and Health-Related Quality of Life Following an Acute Myocardial Infarction. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.485] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
45
|
Grandi S, Filion K, Joseph L, O'Loughlin J, Pilote L, Eisenberg M. Baseline Predictors of Relapse to Smoking at 12 Months in Patients Post-Myocardial Infarction. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.422] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
46
|
Soller L, Knoll M, Ben-Shoshan M, Harrington DW, Fragapane J, Joseph L, St Pierre Y, St Pierre Y, La Vieille S, Wilson K, Elliott SJ, Clarke AE. The prevalence of food allergy among Aboriginal people in Canada. Clin Transl Allergy 2013. [PMCID: PMC3723655 DOI: 10.1186/2045-7022-3-s3-p77] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
47
|
Wu CQ, Grandi SM, Filion KB, Abenhaim HA, Joseph L, Eisenberg MJ. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. BJOG 2013; 120:801-10. [DOI: 10.1111/1471-0528.12210] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/18/2013] [Indexed: 11/27/2022]
Affiliation(s)
| | - SM Grandi
- Center for Clinical Epidemiology; Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal; QC; Canada
| | | | | | | | | |
Collapse
|
48
|
Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 2013; 14:232-44. [PMID: 23171381 DOI: 10.1111/obr.12003] [Citation(s) in RCA: 415] [Impact Index Per Article: 37.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2012] [Revised: 10/09/2012] [Accepted: 10/16/2012] [Indexed: 12/13/2022]
Abstract
Obesity has been associated with elevated levels of C-reactive protein (CRP), a marker of inflammation and predictor of cardiovascular risk. The objective of this systematic review and meta-analysis was to estimate the associations between obesity and CRP according to sex, ethnicity and age. MEDLINE and EMBASE databases were searched through October 2011. Data from 51 cross-sectional studies that used body mass index (BMI), waist circumference (WC) or waist-to-hip ratio (WHR) as measure of obesity were independently extracted by two reviewers and aggregated using random-effects models. The Pearson correlation (r) for BMI and ln(CRP) was 0.36 (95% confidence interval [CI], 0.30-0.42) in adults and 0.37 (CI, 0.31-0.43) in children. In adults, r for BMI and ln(CRP) was greater in women than men by 0.24 (CI, 0.09-0.37), and greater in North Americans/Europeans than Asians by 0.15 (CI, 0-0.28), on average. In North American/European children, the sex difference in r for BMI and ln(CRP) was 0.01 (CI, -0.08 to 0.06). Although limited to anthropometric measures, we found similar results when WC and WHR were used in the analyses. Obesity is associated with elevated levels of CRP and the association is stronger in women and North Americans/Europeans. The sex difference only emerges in adulthood.
Collapse
Affiliation(s)
- J Choi
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
| | | | | |
Collapse
|
49
|
Oskoui M, Joseph L, Dagenais L, Shevell M. Prevalence of cerebral palsy in Quebec: alternative approaches. Neuroepidemiology 2013; 40:264-8. [PMID: 23363886 DOI: 10.1159/000345120] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2012] [Accepted: 09/20/2012] [Indexed: 11/19/2022] Open
Abstract
AIM To provide an estimate of the period prevalence of cerebral palsy (CP) in the province of Quebec. METHODS Children with CP were identified from three consecutive birth cohorts (1999-2001) from the Quebec CP Registry, covering 6 of the 17 administrative health regions of the province. Two inferential approaches were applied for period prevalence estimation, frequentist and bayesian. RESULTS 228 children were identified with CP. Using a frequentist approach, the overall prevalence of CP was 1.84 per 1,000 children aged 9-11 years living in those areas in 2010 (95% CI 1.60-2.08). Using a bayesian approach taking into account the uncertainty about the registry's sensitivity in capturing all cases, the overall prevalence is higher at 2.30 per 1,000 children with a 95% CI (1.99-2.65). CONCLUSION Using a bayesian approach to adjust for the registry's known high specificity and lower sensitivity, the prevalence estimate is in concordance with worldwide estimates and estimates using administrative databases in western Canadian provinces. Future studies are needed to validate the diagnosis of CP within administrative databases and to evaluate possible regional trends across Canada in both prevalence and health service utilization, which may highlight disparities in healthcare delivery.
Collapse
Affiliation(s)
- M Oskoui
- Department of Pediatrics, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada.
| | | | | | | |
Collapse
|
50
|
Abstract
AIMS Vitamin D levels are inversely related to blood pressure. Given that low sun exposure can create a greater reliance on dietary sources of vitamin D, we aimed to determine whether dietary vitamin D and blood pressure associations differ between periods of low and high sun exposure. METHODS Dietary intake, vitamin supplementation, blood pressure, and anthropometric parameters were assessed each season for 1 year (174 adults with Type 2 diabetes). Separate linear regression models were constructed for high and low sun exposure periods to examine associations of systolic blood pressure with dietary vitamin D intake and vitamin supplement use (adjusted for age, gender, BMI, ethnicity, smoking, alcohol, physical activity, antihypertensive medication and nutrient intake). Robustness of findings was confirmed with within-subject repeated measures analysis, including an interaction term for sun exposure period. RESULTS Vitamin D intake from food sources was low year-round and no conclusive association with blood pressure was identified during either period. Systolic blood pressure was 5.1 mmHg lower during the low sun exposure period (95% CI 0.5-9.7) in daily supplement users compared with non-users. The interaction term between supplement use and sun exposure period was significant (low sun exposure* no supplement, P = 0.02). Systolic blood pressure was relatively stable in users (low and high sun exposure periods, respectively, mean ± SE: 135.2 ± 2.6 mmHg and 134.2 ± 2.5 mmHg), but not in non-users (140.2 ± 2.7 mmHg and 130.5 ± 2.5 mmHg). CONCLUSIONS Vitamin supplementation may stabilize systolic blood pressure in adults with Type 2 diabetes across seasons.
Collapse
Affiliation(s)
- S Jarvandi
- Division of Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montreal, Canada
| | | | | | | |
Collapse
|